Quetiapine in recently relapsed patients with schizophrenia: An open-label head-to-head comparative study versus olanzapine

被引：0
|
作者：
Reznik, I
Lilia, S
Shabash, E
Shaked, G
Kertzman, S
Spivak, B
Kotler, M
Weizman, A
机构：
[1] Beer Yaakov Mental Hlth Ctr, Ness Ziona, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Dept Psychiat, IL-69978 Tel Aviv, Israel
来源：
EUROPEAN PSYCHIATRY | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：178S / 178S
页数：1
相关论文
共 50 条
  • [1] Quetiapine ('Seroquel') and olanzapine for acute treatment of patients with schizophrenia: An open-label, comparative study
    Reznik, I
    Slavkin, L
    Shabash, E
    Shaked, G
    Kertzman, S
    Spivak, B
    Weizman, A
    Kotler, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S244 - S244
  • [2] Effects of quetiapine and olanzapine in patients with psychosis and violent behavior: a pilot randomized, open-label, comparative study
    Gobbi, Gabriella
    Comai, Stefano
    Debonnel, Guy
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 757 - 765
  • [3] Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: A 12-week open-label, multicentre clinical trial
    Lublin, Henrik
    Haug, Hans-Joachim
    Koponen, Hannu
    Sigmundsson, Thordur
    Kolb, Stefan A.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2009, 10 (04) : 710 - 718
  • [4] Aripiprazole versus olanzapine in schizophrenia: A 52-week, open-label extension study
    McQuade, R
    Kostic, D
    Marcus, R
    Carson, W
    Iwamoto, T
    Torbeyns, A
    Kerselaers, W
    Yocca, F
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S173 - S174
  • [5] REGARD: what can we learn from randomised, open-label, head-to-head studies?
    Sorensen, Per Soelberg
    LANCET NEUROLOGY, 2008, 7 (10) : 864 - 866
  • [6] An open-label study of olanzapine in the first episode of schizophrenia in adolescents
    Dabokowska, M
    EUROPEAN PSYCHIATRY, 2002, 17 : 115S - 115S
  • [7] Pregabalin Vs. Opioids for the Treatment of Neuropathic Cancer Pain: A Prospective, Head-to-Head, Randomized, Open-Label Study
    Raptis, Efklidis
    Vadalouca, Athina
    Stavropoulou, Evmorfia
    Argyra, Eriphili
    Melemeni, Aikaterini
    Siafaka, Ioanna
    PAIN PRACTICE, 2014, 14 (01) : 32 - 42
  • [8] An Open-Label, Head to Head Comparison Study between Prucalopride and Lactulose for Clozapine Induced Constipation in Patients with Treatment Resistant Schizophrenia
    Damodaran, Ishwary
    Hui, Koh Ong
    Nordin, Amer Siddiq Amer
    Yee, Anne
    Gill, Jesjeet Singh
    Francis, Benedict
    Azhar, Fatin Liyana
    Sulaiman, Ahmad Hatim
    HEALTHCARE, 2020, 8 (04)
  • [9] Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study
    Schjesvold, Fredrik H.
    Dimopoulos, Meletios-Athanasios
    Delimpasi, Sosana
    Robak, Pawel
    Coriu, Daniel
    Legiec, Wojciech
    Pour, Ludek
    Spicka, Ivan
    Masszi, Tamas
    Doronin, Vadim
    Minarik, Jiri
    Salogub, Galina
    Alekseeva, Yulia
    Lazzaro, Antonio
    Maisnar, Vladimir
    Mikala, Gabor
    Rosinol, Laura
    Liberati, Anna Marina
    Symeonidis, Argiris
    Moody, Victoria
    Thuresson, Marcus
    Byrne, Catriona
    Harmenberg, Johan
    Bakker, Nicolaas A.
    Hajek, Roman
    Mateos, Maria-Victoria
    Richardson, Paul G.
    Sonneveld, Pieter
    LANCET HAEMATOLOGY, 2022, 9 (02): : E98 - E110
  • [10] Olanzapine in treatment-refractory schizophrenia: Results of an open-label study
    Martin, J
    Gomez, JC
    GarciaBernardo, E
    Cuesta, M
    Alvarez, E
    Gurpegui, M
    JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 (11) : 479 - 483
12345